mebanazine manufacturers
- Mebanazine
-
- $1980.00
-
2026-05-11
- CAS:65-64-5
- Purity:
- Supply Ability: 10g
|
| | mebanazine Basic information |
| Product Name: | mebanazine | | Synonyms: | mebanazine;1-(α-Methylbenzyl)hydrazine;Actamol;Actomol;Astomol;α-Methylbenzylhydrazine;(alpha-Methylbenzyl)hydrazine;Einecs 200-615-6 | | CAS: | 65-64-5 | | MF: | C8H12N2 | | MW: | 136.19 | | EINECS: | 200-615-6 | | Product Categories: | | | Mol File: | 65-64-5.mol |  |
| | mebanazine Chemical Properties |
| Melting point | 169-170 °C | | Boiling point | 240.49°C (rough estimate) | | density | 0.9672 | | refractive index | 1.5436 | | pka | 7.06±0.70(Predicted) |
| RIDADR | 1851 | | HazardClass | 6.1(b) | | PackingGroup | III |
| | mebanazine Usage And Synthesis |
| Uses | Mebanazine-d5 is the labeled analogue of Mebanazine (M200450), an antidepressant agent. | | Definition | ChEBI: Mebanazine is a member of benzenes. | | in vivo | Mebanazine (90 mg/kg; i.p.; once; mature female rats) decreases the blood giucose level[1].
Mebanazine (1-60 mg/kg; i.p.; once; mature female rats) has the minimal dose which lowered blood glucose after 12 h is 60 mg/kg[1].
| Animal Model: | Mature female rats[1] | | Dosage: | 90 mg/kg | | Administration: | Intraperitoneal injection; once | | Result: | Decreased the blood giucose level after 4-8 h, and continues for 2 days. |
| Animal Model: | Mature female rats[1] | | Dosage: | 0-60 mg/kg | | Administration: | Intraperitoneal injection; once | | Result: | Decreased the blood giucose level in a dose-dependent manner. |
|
| | mebanazine Preparation Products And Raw materials |
|
|
Tag:mebanazine(65-64-5)
Related Product Information
|
|
mebanazine
4-[2-[5-[4-(Diethylamino)phenyl]-4,5-dihydro-1-phenyl-1H-pyrazol-3-yl]vinyl]-N,N-diethylaniline
1,3,5-TRIPHENYL-4,5-DIHYDRO-1H-PYRAZOLE
5-(4-Aminophenyl)-5-methyl-2-phenyl-1,2,4-triazolan-3-one
(S)(-)-5-(alpha-Phenethyl)semioxamizide
(R)(+)-5-(alpha-Phenethyl)semioxamizide
4-(3-Methyl-2-pyrazolin-5-yl)phenol
N-(2,4-Dinitrophenyl)-2-oxa-16-azatetracyclo[11.2.1.0(3,12).0(6,11)]hexadeca-3(12),4,6(11),7,9-pentaen-16-amine
3,4-Diaza-5-(tert-butyl)-2-hydroxy-3-((4-methylphenyl)sulfonyl)tricyclo[6.4.0.0(2,6)]dodeca-1(8),4,9,11-tetraen-7-one
1-(1-(4-chlorophenyl)ethyl)hydrazine
3-(5-CHLORO-2-HYDROXYPHENYL)-3-METHYL-2,3,5,6,7,8-HEXAHYDRO-1,2,4-BENZOTRIAZIN-4-IUM-4-OLATE
1-(1-p-tolylethyl)hydrazine
13,4-DIAZA-5-(TERT-BUTYL)-2-HYDROXY-7-OXOTRICYCLO[6.4.0.0(2,6)]DODECA-1(8),4,9,11-TETRAENE-3-CARBOXAMIDE
3,4-DIMETHYL-1-PHENYL-3A,9B-DIHYDRO-1H-PYRAZOLO[4,3-C]QUINOLIN-5-IUM-5-OLATE
5-(4-HYDROXYPHENYL)-5-METHYL-2-PHENYL-1,2,4-TRIAZOLAN-3-ONE
BUTTPARK 104\40-49
TRANS-2,3-DIPHENYL-1-PHTHALIMIDO- AZIRDINE
1-PHENYL-3-(2-CHLORO-STYRYL)-5-(2-CHLORO-PHENYL)-PYRAZOLIN
|